The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics

被引：15
|
作者：
Wautlet, A. [1 ]
Bachert, C. [2 ,3 ,4 ]
Desrosiers, M. [5 ]
Hellings, Peter W. [6 ,7 ]
Peters, Anju T. [1 ,8 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60610 USA
[2] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, Dept Otorhinolaryngol, Guangzhou, Peoples R China
[4] Univ Ghent, Fac Med, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium
[5] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada
[6] Univ Hosp Leuven, Dept Otorhinolaryngol, Leuven, Belgium
[7] Univ Ghent, Fac Med, Upper Airways Res Lab, Ghent, Belgium
[8] Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60610 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 09期
关键词：
Chronic rhinosinusitis; Nasal polyps; Biologics; RISK-FACTORS; PREVALENCE; OMALIZUMAB; ASTHMA; INFLAMMATION; GENETICS; EFFICACY; SAFETY; STATE;
D O I：
10.1016/j.jaip.2023.04.054
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Chronic rhinosinusitis with nasal polyps affects a significant portion of the worldwide population. This illness is associated with several chronic conditions and has an important impact on patient quality of life, leading to a great societal economic burden. In recent years, biologic medications have been developed and found to be effective in the treatment of chronic rhinosinusitis with nasal polyps. This review focuses on these treatment options and their ability to improve patient outcomes, including quality of life. It also reviews available evidence with regards to patient selection, monitoring of patients after treatment initiation, and comparison of different biologics and with other treatment options such as sinus surgery. & COPY; 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:2642-51)
引用
收藏
页码：2642 / 2651
页数：10
相关论文
共 50 条
  • [21] Management strategies for chronic rhinosinusitis with nasal polyps
    Leggewie, B.
    Gabrielpillai, J.
    Strieth, S.
    HNO, 2022, 70 (01) : 79 - 86
  • [22] Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab
    Klimek L.
    Förster-Ruhrmann U.
    Beule A.G.
    Chaker A.M.
    Hagemann J.
    Klimek F.
    Casper I.
    Huppertz T.
    Hoffmann T.K.
    Dazert S.
    Deitmer T.
    Olze H.
    Strieth S.
    Wrede H.
    Schlenter W.
    Welkoborsky H.-J.
    Wollenberg B.
    Bergmann C.
    Cuevas M.
    Beutner C.
    Gröger M.
    Becker S.
    Allergo Journal International, 2022, 31 (6) : 149 - 160
  • [23] Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey
    Favier, Valentin
    Daveau, Clementine
    Carsuzaa, Florent
    Fieux, Maxime
    Vandersteen, Clair
    Castillo, Laurent
    Papon, Jean Francois
    de Gabory, Ludovic
    Saroul, Nicolas
    Verillaud, Benjamin
    Rumeau, Cecile
    Jankowski, Roger
    Michel, Justin
    de Bonnecaze, Guillaume
    Lecanu, Jean-Baptiste
    Coste, Andre
    Bequignon, Emilie
    Malard, Olivier
    Mortuaire, Geoffrey
    BMJ OPEN, 2024, 14 (05):
  • [24] Practice Patterns of Biologics Prescriptions and Surgery in Chronic Rhinosinusitis With Nasal Polyps
    Almarri, Firas K.
    Algahtani, Saad
    Alokby, Ghassan
    Alanazi, Muteb
    Alsaleh, Saad
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2025, 39 (01) : 49 - 57
  • [25] Switching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience
    Dorling, Marisa
    Sarafan, Masih
    Voizard, Beatrice
    Ammar, Yousif Al
    Hernaiz-Leonardo, Juan Carlos
    Chalmers, Kieran
    Macinnis, Patrick
    Nugent, James
    Janjua, Arif
    Javer, Amin
    Sommer, Doron
    Lee, John
    Chan, Yvonne
    Thamboo, Andrew
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024,
  • [26] Chronic rhinosinusitis with nasal polyps (CRSwNP) - Mepolizumab convinces in real-world studies
    von Weikersthal, Gabi Fischer
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (07) : 551 - 551
  • [27] Application of Biologics in Treating Chronic Rhinosinusitis With Nasal Polyps in Asian Populations
    Kim, Dae Woo
    Yang, Seung Koo
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2022, 15 (02) : 125 - 126
  • [28] Biologics for chronic Rhinosinusitis with Nasal Polyps Facts and Myths about the Prescription
    Nungesser, Jutta
    ALLERGO JOURNAL, 2024, 33 (04) : 86 - 87
  • [29] Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)
    Klimek, Ludger
    Hagemann, Jan
    Welkoborsky, Hans-Jurgen
    Cuevas, Mandy
    Casper, Ingrid
    Foerster-Ruhrmann, Ulrike
    Klimek, Felix
    Hintschich, Constantin A.
    Huppertz, Tilman
    Bergmann, Christoph
    Tomazic, Peter-Valentin
    Becker, Sven
    ALLERGOLOGIE SELECT, 2022, 6 : 148 - 166
  • [30] Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP)
    Lepley, Thomas J.
    Wu, Zhenxing
    Root, Zach
    Mountain, Drew
    Otto, Bradley A.
    Kelly, Kathleen
    Zhao, Kai
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (12) : 1578 - 1580
12345